Archive for the ‘Cardium Therapeutics’ Category

Cardium Therapeutics

October 11th, 2011 | Posted in 2011, Cardium Therapeutics

Cardium Therapeutics – San Diego:  Announced that it has received 510(k) clearance from the FDA to market and sell the company’s new Excellagean Professional-use, sterile, syringe-based advanced wound care product for the management of diabetic foot ulcers and other dermal wounds. The company believes that Excellagen provides a new would care option for the marketplace.

Posted in 2011, Cardium Therapeutics | No Comments »

Cardium Therapeutics

November 19th, 2010 | Posted in Cardium Therapeutics

Cardium Therapeutics, San Diego, announced a co-development and strategic licensing agreement with BioZone Laboratories Inc. for the formulation, manufacture, and licensing of a portfolio of up to 20 aesthetics, advanced skin care formulations and other products for Cardium’s MedPodium product line. Under the terms of the agreement, a product manufactured for Cardium by BioZone will [...]

Posted in Cardium Therapeutics | No Comments »